Do cost-sharing and entry deregulation curb pharmaceutical innovation?

Do cost-sharing and entry deregulation curb pharmaceutical innovation?

This paper examines the role of both cost-sharing schemes in health insurance systems and the regulation of entry into the pharmaceutical sector for pharmaceutical R&D expenditure and drug prices. The analysis suggests that both an increase in the coinsurance rate and stricter price regulations...

Full description

Saved in:
Bibliographic Details
Published in:Journal of health economics Vol. 32; no. 5; pp. 881 - 894
Main Author: Grossmann, Volker
Format: Journal Article
Language:English
Published: Netherlands Elsevier B.V 01-09-2013
Elsevier Sequoia S.A
Subjects:
Coinsurance
Control
Cost engineering
Cost Sharing
Deregulation
Drug and Narcotic Control - legislation & jurisprudence
Drug Costs
Drug Discovery
Drug Industry - legislation & jurisprudence
Economics
Entry deregulation
Expenditures
Health
Health administration
Health insurance
Labor
Models, Statistical
Patent breadth
Patents as Topic
Pharmaceutical industry
Pharmaceutical innovation
Pharmaceuticals
Price regulations
Productivity
Research & development expenditures
Studies
United States
United States
Cost-sharing
Health insurance
Patent breadth
I10
Entry deregulation
L10
Pharmaceutical innovation
O30
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract This paper examines the role of both cost-sharing schemes in health insurance systems and the regulation of entry into the pharmaceutical sector for pharmaceutical R&D expenditure and drug prices. The analysis suggests that both an increase in the coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry deregulation may lead to higher R&D spending of pharmaceutical companies. The relationship between R&D spending per firm and the number of firms may be hump-shaped. In this case, the number of rivals which maximizes R&D expenditure per firm is decreasing in the coinsurance rate and increasing in labor productivity.
AbstractList This paper examines the role of both cost-sharing schemes in health insurance systems and the regulation of entry into the pharmaceutical sector for pharmaceutical R&D expenditure and drug prices. The analysis suggests that both an increase in the coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry deregulation may lead to higher R&D spending of pharmaceutical companies. The relationship between R&D spending per firm and the number of firms may be hump-shaped. In this case, the number of rivals which maximizes R&D expenditure per firm is decreasing in the coinsurance rate and increasing in labor productivity.
This paper examines the role of both cost-sharing schemes in health insurance systems and the regulation of entry into the pharmaceutical sector for pharmaceutical R&D expenditure and drug prices. The analysis suggests that both an increase in the coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry deregulation may lead to higher R&D spending of pharmaceutical companies. The relationship between R&D spending per firm and the number of firms may be hump-shaped. In this case, the number of rivals which maximizes R&D expenditure per firm is decreasing in the coinsurance rate and increasing in labor productivity. [PUBLICATION ABSTRACT]
This paper examines the role of both cost-sharing schemes in health insurance systems and the regulation of entry into the pharmaceutical sector for pharmaceutical R&D expenditure and drug prices. The analysis suggests that both an increase in the coinsurance rate and stricter price regulations adversely affect R&D spending in the pharmaceutical sector. In contrast, entry deregulation may lead to higher R&D spending of pharmaceutical companies. The relationship between R&D spending per firm and the number of firms may be hump-shaped. In this case, the number of rivals which maximizes R&D expenditure per firm is decreasing in the coinsurance rate and increasing in labor productivity.
Author Grossmann, Volker
Author_xml – sequence: 1
  givenname: Volker
  surname: Grossmann
  fullname: Grossmann, Volker
  email: volker.grossmann@unifr.ch
  organization: University of Fribourg, Switzerland
BackLink https://www.ncbi.nlm.nih.gov/pubmed/23896384$$D View this record in MEDLINE/PubMed
BookMark eNqF0U1P3DAQBmCrApWF9i-gSL30ktSfE-fUVpSPSkhc2rPlOBNwlLW3doLEv6-XhR56wRcf_MzYnveUHIUYkJBzRhtGGXyZmukB7YwuNpwy0VBoKGXvyIbptqsZSDgimwLbGngHJ-Q054mWpUT3npxwoTsQWm7I1Y9YuZiXOj_Y5MN9ZcNQYVjSUzVgwvt1touPoXJr6qtdMVvrcF28s3PlQ4iPz8dfP5Dj0c4ZP77sZ-T31eWvi5v69u7658X329opyZZajkJw51oNAApHhUwqKS0bhON8GDtUbes01x0yqrq-d4oyBoPk0FOrWy3OyOdD312Kf1bMi9n67HCebcC4ZsNAq1YrkOxtKqWQFBSnhX76j05xTaF8ZK_KeFV5cFFwUC7FnBOOZpf81qYnw6jZh2Im8xqK2YdiKJgSSik8f2m_9lsc_pW9plDAtwPAMrpHj8lk5zE4HHxCt5gh-rfu-AuCgKCh
CitedBy_id crossref_primary_10_1016_j_jeoa_2020_100286
crossref_primary_10_2139_ssrn_3060004
crossref_primary_10_2139_ssrn_2912541
crossref_primary_10_1111_radm_12691
crossref_primary_10_1111_geer_12198
crossref_primary_10_1515_bejeap_2016_0309
crossref_primary_10_1515_fhep_2016_0011
Cites_doi 10.2307/2950496
10.1257/jep.5.1.29
10.1111/1467-937X.00097
10.1162/0033553041502144
10.2307/2298044
10.1016/0166-0462(93)90005-Y
10.1787/health_glance-2010-en
10.1086/426882
10.1377/hlthaff.28.1.w138
10.1257/000282806777211766
10.1162/rest.91.1.20
10.1257/089533002320950975
10.1257/jep.7.3.97
10.1016/S0167-6296(00)00072-2
10.2307/2231788
10.1016/S1574-0684(05)01002-6
10.2307/2555498
10.1111/j.1538-4616.2008.00197.x
10.1001/jama.298.1.61
10.1016/j.jhealeco.2005.09.004
10.1186/1475-9276-7-12
10.1016/0022-1996(81)90001-5
10.2307/2556088
10.2307/2555929
10.1016/S0167-7187(97)00031-3
10.2202/1558-9544.1006
10.1023/A:1009826304308
10.1016/j.jpubeco.2012.10.003
10.1111/j.1430-9134.1998.00001.x
10.1023/B:JOEG.0000023017.42109.c2
10.1111/1468-0297.00626
10.2307/2555497
10.2307/2555432
10.1016/j.jpubeco.2013.03.001
10.4284/sej.2009.76.2.351
10.1002/hec.897
10.1016/j.jpubeco.2008.11.003
10.1377/hlthaff.28.1.w125
10.1162/003355302753399436
ContentType Journal Article
Copyright 2013 Elsevier B.V.
Copyright © 2013 Elsevier B.V. All rights reserved.
Copyright Elsevier Science Ltd. Sep 2013
Copyright_xml – notice: 2013 Elsevier B.V.
– notice: Copyright © 2013 Elsevier B.V. All rights reserved.
– notice: Copyright Elsevier Science Ltd. Sep 2013
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QJ
7T2
8BJ
C1K
FQK
JBE
K9.
7X8
8FD
FR3
KR7
DOI 10.1016/j.jhealeco.2013.06.001
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Applied Social Sciences Index & Abstracts (ASSIA)
Health and Safety Science Abstracts (Full archive)
International Bibliography of the Social Sciences (IBSS)
Environmental Sciences and Pollution Management
International Bibliography of the Social Sciences
International Bibliography of the Social Sciences
ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Technology Research Database
Engineering Research Database
Civil Engineering Abstracts
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
ProQuest Health & Medical Complete (Alumni)
Health & Safety Science Abstracts
International Bibliography of the Social Sciences (IBSS)
Applied Social Sciences Index and Abstracts (ASSIA)
Environmental Sciences and Pollution Management
MEDLINE - Academic
Technology Research Database
Civil Engineering Abstracts
Engineering Research Database
DatabaseTitleList Technology Research Database
MEDLINE

ProQuest Health & Medical Complete (Alumni)
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
Economics
EISSN 1879-1646
EndPage 894
ExternalDocumentID 3092973451
10_1016_j_jhealeco_2013_06_001
23896384
S0167629613000878
Genre Journal Article
Feature
GeographicLocations United States
GeographicLocations_xml – name: United States
GroupedDBID ---
--K
--M
--Z
-DZ
-~X
..I
.~1
0R~
186
1B1
1OL
1RT
1~.
1~5
29K
3R3
4.4
457
4G.
53G
5GY
5VS
63O
7-5
71M
8P~
9JM
9JO
AABNK
AACTN
AAEDT
AAEDW
AAFFL
AAFJI
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAPFB
AAQFI
AAQXK
AAWTL
AAXUO
ABBQC
ABFNM
ABFRF
ABJNI
ABLJU
ABLVK
ABMAC
ABMZM
ABOCM
ABXDB
ABYKQ
ACDAQ
ACGFO
ACGFS
ACHQT
ACNCT
ACPRK
ACRLP
ACROA
ADBBV
ADEZE
ADFHU
ADIYS
ADMUD
AEBSH
AEFWE
AEKER
AENEX
AETEA
AEYQN
AFFDN
AFFNX
AFKWA
AFODL
AFRAH
AFTJW
AFXIZ
AGHFR
AGTHC
AGUBO
AGYEJ
AHHHB
AHMBA
AIEXJ
AIIAU
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJWLA
AKYCK
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AOMHK
ASPBG
AVARZ
AVWKF
AXJTR
AXLSJ
AZFZN
BEHZQ
BEZPJ
BGSCR
BKOJK
BKOMP
BLXMC
BNPGV
BNTGB
BPUDD
BULVW
BZJEE
CS3
D-I
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-2
G-Q
GBLVA
HEH
HMB
HMK
HMO
HVGLF
HZ~
IHE
IXIXF
J1W
KOM
LCYCR
LPU
LY5
M29
M3W
M41
MO0
MS~
MVM
N9A
O-L
O9-
OAUVE
OZT
P-8
P-9
P2P
PC.
PQQKQ
PRBVW
Q38
R2-
RIG
ROL
RPZ
RXW
SAE
SCC
SDF
SDG
SDP
SEB
SEE
SES
SEW
SPCBC
SSB
SSF
SSH
SSO
SSZ
T5K
TAE
U5U
ULY
UNMZH
VQA
WUQ
YK3
~G-
AAXKI
ADVLN
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QJ
7T2
8BJ
C1K
FQK
JBE
K9.
7X8
8FD
FR3
KR7
ID FETCH-LOGICAL-c541t-4f332cc786665ef5e14544a1d3c22df9e577c8289e1059bbc50116d426b0a8783
ISSN 0167-6296
IngestDate Fri Oct 25 09:11:54 EDT 2024
Sat Oct 26 00:12:29 EDT 2024
Thu Oct 10 19:06:10 EDT 2024
Thu Nov 21 20:54:44 EST 2024
Sat Sep 28 07:54:42 EDT 2024
Fri Feb 23 02:20:43 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Cost-sharing
Health insurance
Patent breadth
I10
Entry deregulation
L10
Pharmaceutical innovation
O30
Language English
License Copyright © 2013 Elsevier B.V. All rights reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c541t-4f332cc786665ef5e14544a1d3c22df9e577c8289e1059bbc50116d426b0a8783
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
OpenAccessLink https://www.econstor.eu/bitstream/10419/46570/1/660775697.pdf
PMID 23896384
PQID 1440135866
PQPubID 46287
PageCount 14
ParticipantIDs proquest_miscellaneous_1685785641
proquest_miscellaneous_1443406520
proquest_journals_1440135866
crossref_primary_10_1016_j_jhealeco_2013_06_001
pubmed_primary_23896384
elsevier_sciencedirect_doi_10_1016_j_jhealeco_2013_06_001
PublicationCentury 2000
PublicationDate 2013-09-01
PublicationDateYYYYMMDD 2013-09-01
PublicationDate_xml – month: 09
  year: 2013
  text: 2013-09-01
  day: 01
PublicationDecade 2010
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
– name: Amsterdam
PublicationTitle Journal of health economics
PublicationTitleAlternate J Health Econ
PublicationYear 2013
Publisher Elsevier B.V
Elsevier Sequoia S.A
Publisher_xml – name: Elsevier B.V
– name: Elsevier Sequoia S.A
References Lancaster (bib0165) 1979
Sanso, Aísa (bib0200) 2006; 25
Scotchmer (bib0215) 1996; 27
Aghion, Howitt (bib0025) 2005
Grossmann (bib0120) 2011
Grossman, Helpman (bib0115) 1991; 58
Aghion, Bloom, Blundell, Griffith, Howitt (bib0015) 2005; 120
Brekke, Straume (bib0050) 2009; 76
Gallini (bib0085) 1992; 23
Aghion, Blundell, Griffith, Howitt, Prantl (bib0020) 2009; 91
O’Donoghue, Zweimüller (bib0185) 2004; 9
The Economist (bib0235) 2011
Klemperer (bib0145) 1990; 21
Gilbert, Shapiro (bib0105) 1990; 21
Li (bib0170) 2001; 111
Goldman, Joyce, Zheng (bib0110) 2007; 298
O’Donoghue, Scotchmer, Thisse (bib0180) 1998; 7
Blundell, Griffith, Van Reenen (bib0045) 1999; 66
Helpman (bib0125) 1981; 11
Djankov, La Porta, Lopez-de-Silanes, Shleifer (bib0070) 2002; 116
Gemmill, Thomson, Mossialos (bib0095) 2008; 7
Lakdawalla, Sood (bib0155) 2013; 102
Scotchmer (bib0210) 1991; 5
O’Donoghue (bib0175) 1997; 29
Dixit, Stiglitz (bib0065) 1977; 67
Lakdawalla, Sood (bib0150) 2009; 93
Jones, Williams (bib0140) 2000; 5
Berndt (bib0035) 2002; 16
Aghion, Howitt (bib0030) 2009
Acemoglu, Cutler, Finkelstein, Linn (bib0005) 2006; 96
Sood, de Vries, Gutierrez, Lakdawalla, Goldman (bib0220) 2009; 28
Vincenzo (bib0250) 1996; 44
OECD (bib0190) 2010
Wright (bib0260) 1999; 17
Hummels, Lugovsky (bib0130) 2009; 41
Giaccotto, Santerre, Vernon (bib0100) 2005; 48
Blume-Kohout, Sood (bib0040) 2013; 97
Cai, Mavromaras, Oguzoglu (bib0055) 2008
Wong (bib0255) 1995
Garber, Jones, Romer (bib0090) 2006; 9
Dasgupta, Stiglitz (bib0060) 1980; 90
Lakdawalla, Goldman, Michaud, Sood, Lempert, Cong, de Vries, Gutierrez (bib0160) 2009; 28
Ethier (bib0080) 1982; 72
Acemoglu, Linn (bib0010) 2004; 119
Economides (bib0075) 1993; 23
Van Zona, Muysken (bib0240) 2001; 20
Scherer (bib0205) 1993; 7
Sutton (bib0230) 1998
Vernon (bib0245) 2005; 14
Sutton (bib0225) 1991
Ethier (10.1016/j.jhealeco.2013.06.001_bib0080) 1982; 72
Lancaster (10.1016/j.jhealeco.2013.06.001_bib0165) 1979
Garber (10.1016/j.jhealeco.2013.06.001_bib0090) 2006; 9
Hummels (10.1016/j.jhealeco.2013.06.001_bib0130) 2009; 41
Lakdawalla (10.1016/j.jhealeco.2013.06.001_bib0160) 2009; 28
The Economist (10.1016/j.jhealeco.2013.06.001_bib0235) 2011
Acemoglu (10.1016/j.jhealeco.2013.06.001_bib0010) 2004; 119
OECD (10.1016/j.jhealeco.2013.06.001_bib0190) 2010
Sood (10.1016/j.jhealeco.2013.06.001_bib0220) 2009; 28
Dixit (10.1016/j.jhealeco.2013.06.001_bib0065) 1977; 67
Lakdawalla (10.1016/j.jhealeco.2013.06.001_bib0150) 2009; 93
Grossmann (10.1016/j.jhealeco.2013.06.001_bib0120) 2011
Gilbert (10.1016/j.jhealeco.2013.06.001_bib0105) 1990; 21
Blume-Kohout (10.1016/j.jhealeco.2013.06.001_bib0040) 2013; 97
Economides (10.1016/j.jhealeco.2013.06.001_bib0075) 1993; 23
Jones (10.1016/j.jhealeco.2013.06.001_bib0140) 2000; 5
Aghion (10.1016/j.jhealeco.2013.06.001_bib0020) 2009; 91
Giaccotto (10.1016/j.jhealeco.2013.06.001_bib0100) 2005; 48
O’Donoghue (10.1016/j.jhealeco.2013.06.001_bib0185) 2004; 9
Scotchmer (10.1016/j.jhealeco.2013.06.001_bib0215) 1996; 27
Berndt (10.1016/j.jhealeco.2013.06.001_bib0035) 2002; 16
Blundell (10.1016/j.jhealeco.2013.06.001_bib0045) 1999; 66
Dasgupta (10.1016/j.jhealeco.2013.06.001_bib0060) 1980; 90
Wong (10.1016/j.jhealeco.2013.06.001_bib0255) 1995
Sanso (10.1016/j.jhealeco.2013.06.001_bib0200) 2006; 25
Grossman (10.1016/j.jhealeco.2013.06.001_bib0115) 1991; 58
Scotchmer (10.1016/j.jhealeco.2013.06.001_bib0210) 1991; 5
Vincenzo (10.1016/j.jhealeco.2013.06.001_bib0250) 1996; 44
Goldman (10.1016/j.jhealeco.2013.06.001_bib0110) 2007; 298
Li (10.1016/j.jhealeco.2013.06.001_bib0170) 2001; 111
Gemmill (10.1016/j.jhealeco.2013.06.001_bib0095) 2008; 7
Helpman (10.1016/j.jhealeco.2013.06.001_bib0125) 1981; 11
Gallini (10.1016/j.jhealeco.2013.06.001_bib0085) 1992; 23
Van Zona (10.1016/j.jhealeco.2013.06.001_bib0240) 2001; 20
Aghion (10.1016/j.jhealeco.2013.06.001_bib0030) 2009
Sutton (10.1016/j.jhealeco.2013.06.001_bib0230) 1998
Djankov (10.1016/j.jhealeco.2013.06.001_bib0070) 2002; 116
Sutton (10.1016/j.jhealeco.2013.06.001_bib0225) 1991
Aghion (10.1016/j.jhealeco.2013.06.001_bib0025) 2005
O’Donoghue (10.1016/j.jhealeco.2013.06.001_bib0175) 1997; 29
Aghion (10.1016/j.jhealeco.2013.06.001_bib0015) 2005; 120
Scherer (10.1016/j.jhealeco.2013.06.001_bib0205) 1993; 7
Klemperer (10.1016/j.jhealeco.2013.06.001_bib0145) 1990; 21
Vernon (10.1016/j.jhealeco.2013.06.001_bib0245) 2005; 14
Cai (10.1016/j.jhealeco.2013.06.001_bib0055) 2008
Wright (10.1016/j.jhealeco.2013.06.001_bib0260) 1999; 17
Lakdawalla (10.1016/j.jhealeco.2013.06.001_bib0155) 2013; 102
Brekke (10.1016/j.jhealeco.2013.06.001_bib0050) 2009; 76
O’Donoghue (10.1016/j.jhealeco.2013.06.001_bib0180) 1998; 7
Acemoglu (10.1016/j.jhealeco.2013.06.001_bib0005) 2006; 96
References_xml – volume: 17
  start-page: 419
  year: 1999
  end-page: 436
  ident: bib0260
  article-title: Optimal patent breadth and length with costly imitation
  publication-title: International Journal of Industrial Organization
  contributor:
    fullname: Wright
– volume: 29
  start-page: 654
  year: 1997
  end-page: 679
  ident: bib0175
  article-title: A patentability requirement for sequential innovation
  publication-title: RAND Journal of Economics
  contributor:
    fullname: O’Donoghue
– volume: 120
  start-page: 701
  year: 2005
  end-page: 728
  ident: bib0015
  article-title: Competition and innovation: an inverted U relationship
  publication-title: Quarterly Journal of Economics
  contributor:
    fullname: Howitt
– volume: 93
  start-page: 541
  year: 2009
  end-page: 548
  ident: bib0150
  article-title: Innovation and the welfare effects of public drug insurance
  publication-title: Journal of Public Economics
  contributor:
    fullname: Sood
– volume: 96
  start-page: 103
  year: 2006
  end-page: 107
  ident: bib0005
  article-title: Did medicare induce pharmaceutical innovation?
  publication-title: American Economic Association Papers and Proceedings
  contributor:
    fullname: Linn
– volume: 102
  start-page: 1
  year: 2013
  end-page: 70
  ident: bib0155
  article-title: Health insurance as a two-part pricing contract
  publication-title: Journal of Public Economics
  contributor:
    fullname: Sood
– year: 2008
  ident: bib0055
  article-title: The Effects of Health and Health Shocks on Hours Worked
  contributor:
    fullname: Oguzoglu
– volume: 9
  year: 2006
  ident: bib0090
  article-title: Insurance and incentives for medical innovation
  publication-title: Forum for Health Economics & Policy
  contributor:
    fullname: Romer
– volume: 28
  start-page: 138
  year: 2009
  end-page: 150
  ident: bib0160
  article-title: US pharmaceutical policy in a global marketplace
  publication-title: Health Affairs
  contributor:
    fullname: Gutierrez
– volume: 21
  start-page: 106
  year: 1990
  end-page: 112
  ident: bib0105
  article-title: Optimal patent length and breadth
  publication-title: RAND Journal of Economics
  contributor:
    fullname: Shapiro
– volume: 44
  start-page: 249
  year: 1996
  end-page: 265
  ident: bib0250
  article-title: Patent races and optimal patent breadth and length
  publication-title: Journal of Industrial Economics
  contributor:
    fullname: Vincenzo
– volume: 66
  start-page: 529
  year: 1999
  end-page: 554
  ident: bib0045
  article-title: Market share, market value and innovation in a panel of British manufacturing firms
  publication-title: Review of Economic Studies
  contributor:
    fullname: Van Reenen
– volume: 41
  start-page: 3
  year: 2009
  end-page: 33
  ident: bib0130
  article-title: Trade in ideal varieties: theory and evidence
  publication-title: Journal of Money, Credit and Banking
  contributor:
    fullname: Lugovsky
– volume: 111
  start-page: C164
  year: 2001
  end-page: C179
  ident: bib0170
  article-title: On the policy implications of endogenous technological progress
  publication-title: Economic Journal
  contributor:
    fullname: Li
– volume: 119
  start-page: 1049
  year: 2004
  end-page: 1090
  ident: bib0010
  article-title: Market size in innovation: theory and evidence from the pharmaceutical industry
  publication-title: Quarterly Journal of Economics
  contributor:
    fullname: Linn
– volume: 58
  start-page: 43
  year: 1991
  end-page: 61
  ident: bib0115
  article-title: Quality ladders in the theory of growth
  publication-title: Review of Economic Studies
  contributor:
    fullname: Helpman
– volume: 5
  start-page: 65
  year: 2000
  end-page: 85
  ident: bib0140
  article-title: Too much of a good thing? The economics of investment in R&D
  publication-title: Journal of Economic Growth
  contributor:
    fullname: Williams
– volume: 21
  start-page: 113
  year: 1990
  end-page: 130
  ident: bib0145
  article-title: How broad should the scope of patent protection be?
  publication-title: RAND Journal of Economics
  contributor:
    fullname: Klemperer
– volume: 5
  start-page: 29
  year: 1991
  end-page: 41
  ident: bib0210
  article-title: Standing on the shoulders of giants: cumulative research and patent law
  publication-title: Journal of Economic Perspectives
  contributor:
    fullname: Scotchmer
– volume: 28
  start-page: 125
  year: 2009
  end-page: 137
  ident: bib0220
  article-title: The effect of pharmaceutical regulation on revenues
  publication-title: Health Affairs
  contributor:
    fullname: Goldman
– volume: 9
  start-page: 81
  year: 2004
  end-page: 123
  ident: bib0185
  article-title: Patents in a Model of Endogenous Growth
  publication-title: Journal of Economic Growth
  contributor:
    fullname: Zweimüller
– year: 1998
  ident: bib0230
  article-title: Technology and Market Structure
  contributor:
    fullname: Sutton
– volume: 91
  start-page: 20
  year: 2009
  end-page: 32
  ident: bib0020
  article-title: The effects of entry on incumbent innovation and productivity
  publication-title: Review of Economics and Statistics
  contributor:
    fullname: Prantl
– year: 2010
  ident: bib0190
  article-title: Health at a Glance: Europe 2010
  contributor:
    fullname: OECD
– volume: 23
  start-page: 235
  year: 1993
  end-page: 257
  ident: bib0075
  article-title: Quality variations in the circular model of variety-differentiated products
  publication-title: Regional Science and Urban Economics
  contributor:
    fullname: Economides
– year: 1991
  ident: bib0225
  article-title: Sunk Costs and Market Structure: Price Competition, Advertising, and the Evolution of Concentration
  contributor:
    fullname: Sutton
– volume: 76
  start-page: 351
  year: 2009
  end-page: 374
  ident: bib0050
  article-title: Pharmaceutical patents: incentives for research and development or marketing?
  publication-title: Southern Economic Journal
  contributor:
    fullname: Straume
– volume: 11
  start-page: 305
  year: 1981
  end-page: 340
  ident: bib0125
  article-title: International trade in the presence of product differentiation, economies of scale and monopolistic competition
  publication-title: Journal of International Economics
  contributor:
    fullname: Helpman
– volume: 27
  start-page: 117
  year: 1996
  end-page: 126
  ident: bib0215
  article-title: Protecting early innovators: should second generation products be patentable?
  publication-title: RAND Journal of Economics
  contributor:
    fullname: Scotchmer
– volume: 48
  start-page: 195
  year: 2005
  end-page: 214
  ident: bib0100
  article-title: Drug prices and research and development investment behavior in the pharmaceutical industry
  publication-title: Journal of Law and Economics
  contributor:
    fullname: Vernon
– volume: 90
  start-page: 266
  year: 1980
  end-page: 293
  ident: bib0060
  article-title: Industrial structure and the nature of innovative activity
  publication-title: Economic Journal
  contributor:
    fullname: Stiglitz
– year: 1979
  ident: bib0165
  article-title: Variety, Equity, and Efficiency
  contributor:
    fullname: Lancaster
– start-page: 70
  year: 2011
  end-page: 72
  ident: bib0235
  article-title: Resistance to Antibiotics: The Spread of Superbugs
  contributor:
    fullname: The Economist
– volume: 25
  start-page: 555
  year: 2006
  end-page: 578
  ident: bib0200
  article-title: Endogenous longevity, biological deterioration and economic growth
  publication-title: Journal of Health Economics
  contributor:
    fullname: Aísa
– volume: 298
  start-page: 61
  year: 2007
  end-page: 69
  ident: bib0110
  article-title: Prescription drug cost sharing: associations with medication and medical utilization and spending and health
  publication-title: Journal of the American Medical Association
  contributor:
    fullname: Zheng
– volume: 7
  start-page: 97
  year: 1993
  end-page: 115
  ident: bib0205
  article-title: Pricing, profits, and technological progress in the pharmaceutical industry
  publication-title: Journal of Economic Perspectives
  contributor:
    fullname: Scherer
– volume: 116
  start-page: 1
  year: 2002
  end-page: 37
  ident: bib0070
  article-title: The regulation of entry
  publication-title: Quarterly Journal of Economics
  contributor:
    fullname: Shleifer
– volume: 23
  start-page: 52
  year: 1992
  end-page: 63
  ident: bib0085
  article-title: Patent policy and costly imitation
  publication-title: RAND Journal of Economics
  contributor:
    fullname: Gallini
– start-page: 67
  year: 2005
  end-page: 110
  ident: bib0025
  article-title: Growth with quality-improving innovations: an integrated framework
  publication-title: Handbook of Economic Growth
  contributor:
    fullname: Howitt
– volume: 67
  start-page: 297
  year: 1977
  end-page: 308
  ident: bib0065
  article-title: Monopolistic competition and optimum product diversity
  publication-title: American Economic Review
  contributor:
    fullname: Stiglitz
– volume: 14
  start-page: 1
  year: 2005
  end-page: 16
  ident: bib0245
  article-title: Examining the link between price regulation and pharmaceutical R&D investment
  publication-title: Health Economics
  contributor:
    fullname: Vernon
– volume: 16
  start-page: 45
  year: 2002
  end-page: 66
  ident: bib0035
  article-title: Pharmaceuticals in U.S. Health Care: determinants of quantity and price
  publication-title: Journal of Economic Perspectives
  contributor:
    fullname: Berndt
– volume: 20
  start-page: 169
  year: 2001
  end-page: 185
  ident: bib0240
  article-title: Health and endogenous growth
  publication-title: Journal of Health Economics
  contributor:
    fullname: Muysken
– volume: 7
  start-page: 1
  year: 1998
  end-page: 32
  ident: bib0180
  article-title: Patent breadth, patent life, and the pace of technological progress
  publication-title: Journal of Economics and Management Strategy
  contributor:
    fullname: Thisse
– volume: 97
  start-page: 327
  year: 2013
  end-page: 336
  ident: bib0040
  article-title: Market size and innovation: effects of medicare part D on pharmaceuticals research and development
  publication-title: Journal of Public Economics
  contributor:
    fullname: Sood
– volume: 72
  start-page: 389
  year: 1982
  end-page: 405
  ident: bib0080
  article-title: National and international returns to scale in the modern theory of international trade
  publication-title: American Economic Review
  contributor:
    fullname: Ethier
– year: 2011
  ident: bib0120
  article-title: Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?
  contributor:
    fullname: Grossmann
– year: 2009
  ident: bib0030
  article-title: The Economics of Growth
  contributor:
    fullname: Howitt
– volume: 7
  start-page: 12
  year: 2008
  ident: bib0095
  article-title: What impact do prescription drug charges have on efficiency and equity
  publication-title: International Journal for Equity in Health
  contributor:
    fullname: Mossialos
– year: 1995
  ident: bib0255
  article-title: International Trade in Goods and Factor Mobility
  contributor:
    fullname: Wong
– volume: 44
  start-page: 249
  year: 1996
  ident: 10.1016/j.jhealeco.2013.06.001_bib0250
  article-title: Patent races and optimal patent breadth and length
  publication-title: Journal of Industrial Economics
  doi: 10.2307/2950496
  contributor:
    fullname: Vincenzo
– volume: 5
  start-page: 29
  year: 1991
  ident: 10.1016/j.jhealeco.2013.06.001_bib0210
  article-title: Standing on the shoulders of giants: cumulative research and patent law
  publication-title: Journal of Economic Perspectives
  doi: 10.1257/jep.5.1.29
  contributor:
    fullname: Scotchmer
– year: 1995
  ident: 10.1016/j.jhealeco.2013.06.001_bib0255
  contributor:
    fullname: Wong
– volume: 66
  start-page: 529
  year: 1999
  ident: 10.1016/j.jhealeco.2013.06.001_bib0045
  article-title: Market share, market value and innovation in a panel of British manufacturing firms
  publication-title: Review of Economic Studies
  doi: 10.1111/1467-937X.00097
  contributor:
    fullname: Blundell
– volume: 119
  start-page: 1049
  year: 2004
  ident: 10.1016/j.jhealeco.2013.06.001_bib0010
  article-title: Market size in innovation: theory and evidence from the pharmaceutical industry
  publication-title: Quarterly Journal of Economics
  doi: 10.1162/0033553041502144
  contributor:
    fullname: Acemoglu
– volume: 58
  start-page: 43
  year: 1991
  ident: 10.1016/j.jhealeco.2013.06.001_bib0115
  article-title: Quality ladders in the theory of growth
  publication-title: Review of Economic Studies
  doi: 10.2307/2298044
  contributor:
    fullname: Grossman
– volume: 23
  start-page: 235
  year: 1993
  ident: 10.1016/j.jhealeco.2013.06.001_bib0075
  article-title: Quality variations in the circular model of variety-differentiated products
  publication-title: Regional Science and Urban Economics
  doi: 10.1016/0166-0462(93)90005-Y
  contributor:
    fullname: Economides
– year: 2010
  ident: 10.1016/j.jhealeco.2013.06.001_bib0190
  doi: 10.1787/health_glance-2010-en
  contributor:
    fullname: OECD
– volume: 48
  start-page: 195
  year: 2005
  ident: 10.1016/j.jhealeco.2013.06.001_bib0100
  article-title: Drug prices and research and development investment behavior in the pharmaceutical industry
  publication-title: Journal of Law and Economics
  doi: 10.1086/426882
  contributor:
    fullname: Giaccotto
– volume: 120
  start-page: 701
  year: 2005
  ident: 10.1016/j.jhealeco.2013.06.001_bib0015
  article-title: Competition and innovation: an inverted U relationship
  publication-title: Quarterly Journal of Economics
  contributor:
    fullname: Aghion
– volume: 28
  start-page: 138
  year: 2009
  ident: 10.1016/j.jhealeco.2013.06.001_bib0160
  article-title: US pharmaceutical policy in a global marketplace
  publication-title: Health Affairs
  doi: 10.1377/hlthaff.28.1.w138
  contributor:
    fullname: Lakdawalla
– year: 2008
  ident: 10.1016/j.jhealeco.2013.06.001_bib0055
  contributor:
    fullname: Cai
– volume: 96
  start-page: 103
  year: 2006
  ident: 10.1016/j.jhealeco.2013.06.001_bib0005
  article-title: Did medicare induce pharmaceutical innovation?
  publication-title: American Economic Association Papers and Proceedings
  doi: 10.1257/000282806777211766
  contributor:
    fullname: Acemoglu
– volume: 91
  start-page: 20
  year: 2009
  ident: 10.1016/j.jhealeco.2013.06.001_bib0020
  article-title: The effects of entry on incumbent innovation and productivity
  publication-title: Review of Economics and Statistics
  doi: 10.1162/rest.91.1.20
  contributor:
    fullname: Aghion
– volume: 16
  start-page: 45
  year: 2002
  ident: 10.1016/j.jhealeco.2013.06.001_bib0035
  article-title: Pharmaceuticals in U.S. Health Care: determinants of quantity and price
  publication-title: Journal of Economic Perspectives
  doi: 10.1257/089533002320950975
  contributor:
    fullname: Berndt
– volume: 7
  start-page: 97
  year: 1993
  ident: 10.1016/j.jhealeco.2013.06.001_bib0205
  article-title: Pricing, profits, and technological progress in the pharmaceutical industry
  publication-title: Journal of Economic Perspectives
  doi: 10.1257/jep.7.3.97
  contributor:
    fullname: Scherer
– start-page: 70
  year: 2011
  ident: 10.1016/j.jhealeco.2013.06.001_bib0235
  contributor:
    fullname: The Economist
– volume: 20
  start-page: 169
  year: 2001
  ident: 10.1016/j.jhealeco.2013.06.001_bib0240
  article-title: Health and endogenous growth
  publication-title: Journal of Health Economics
  doi: 10.1016/S0167-6296(00)00072-2
  contributor:
    fullname: Van Zona
– volume: 90
  start-page: 266
  year: 1980
  ident: 10.1016/j.jhealeco.2013.06.001_bib0060
  article-title: Industrial structure and the nature of innovative activity
  publication-title: Economic Journal
  doi: 10.2307/2231788
  contributor:
    fullname: Dasgupta
– start-page: 67
  year: 2005
  ident: 10.1016/j.jhealeco.2013.06.001_bib0025
  article-title: Growth with quality-improving innovations: an integrated framework
  doi: 10.1016/S1574-0684(05)01002-6
  contributor:
    fullname: Aghion
– volume: 21
  start-page: 113
  year: 1990
  ident: 10.1016/j.jhealeco.2013.06.001_bib0145
  article-title: How broad should the scope of patent protection be?
  publication-title: RAND Journal of Economics
  doi: 10.2307/2555498
  contributor:
    fullname: Klemperer
– volume: 41
  start-page: 3
  year: 2009
  ident: 10.1016/j.jhealeco.2013.06.001_bib0130
  article-title: Trade in ideal varieties: theory and evidence
  publication-title: Journal of Money, Credit and Banking
  doi: 10.1111/j.1538-4616.2008.00197.x
  contributor:
    fullname: Hummels
– volume: 298
  start-page: 61
  year: 2007
  ident: 10.1016/j.jhealeco.2013.06.001_bib0110
  article-title: Prescription drug cost sharing: associations with medication and medical utilization and spending and health
  publication-title: Journal of the American Medical Association
  doi: 10.1001/jama.298.1.61
  contributor:
    fullname: Goldman
– volume: 67
  start-page: 297
  year: 1977
  ident: 10.1016/j.jhealeco.2013.06.001_bib0065
  article-title: Monopolistic competition and optimum product diversity
  publication-title: American Economic Review
  contributor:
    fullname: Dixit
– volume: 25
  start-page: 555
  year: 2006
  ident: 10.1016/j.jhealeco.2013.06.001_bib0200
  article-title: Endogenous longevity, biological deterioration and economic growth
  publication-title: Journal of Health Economics
  doi: 10.1016/j.jhealeco.2005.09.004
  contributor:
    fullname: Sanso
– volume: 7
  start-page: 12
  year: 2008
  ident: 10.1016/j.jhealeco.2013.06.001_bib0095
  article-title: What impact do prescription drug charges have on efficiency and equity
  publication-title: International Journal for Equity in Health
  doi: 10.1186/1475-9276-7-12
  contributor:
    fullname: Gemmill
– volume: 11
  start-page: 305
  year: 1981
  ident: 10.1016/j.jhealeco.2013.06.001_bib0125
  article-title: International trade in the presence of product differentiation, economies of scale and monopolistic competition
  publication-title: Journal of International Economics
  doi: 10.1016/0022-1996(81)90001-5
  contributor:
    fullname: Helpman
– volume: 29
  start-page: 654
  year: 1997
  ident: 10.1016/j.jhealeco.2013.06.001_bib0175
  article-title: A patentability requirement for sequential innovation
  publication-title: RAND Journal of Economics
  doi: 10.2307/2556088
  contributor:
    fullname: O’Donoghue
– year: 2009
  ident: 10.1016/j.jhealeco.2013.06.001_bib0030
  contributor:
    fullname: Aghion
– volume: 27
  start-page: 117
  year: 1996
  ident: 10.1016/j.jhealeco.2013.06.001_bib0215
  article-title: Protecting early innovators: should second generation products be patentable?
  publication-title: RAND Journal of Economics
  doi: 10.2307/2555929
  contributor:
    fullname: Scotchmer
– volume: 17
  start-page: 419
  year: 1999
  ident: 10.1016/j.jhealeco.2013.06.001_bib0260
  article-title: Optimal patent breadth and length with costly imitation
  publication-title: International Journal of Industrial Organization
  doi: 10.1016/S0167-7187(97)00031-3
  contributor:
    fullname: Wright
– volume: 9
  issue: 2
  year: 2006
  ident: 10.1016/j.jhealeco.2013.06.001_bib0090
  article-title: Insurance and incentives for medical innovation
  publication-title: Forum for Health Economics & Policy
  doi: 10.2202/1558-9544.1006
  contributor:
    fullname: Garber
– volume: 5
  start-page: 65
  year: 2000
  ident: 10.1016/j.jhealeco.2013.06.001_bib0140
  article-title: Too much of a good thing? The economics of investment in R&D
  publication-title: Journal of Economic Growth
  doi: 10.1023/A:1009826304308
  contributor:
    fullname: Jones
– volume: 97
  start-page: 327
  year: 2013
  ident: 10.1016/j.jhealeco.2013.06.001_bib0040
  article-title: Market size and innovation: effects of medicare part D on pharmaceuticals research and development
  publication-title: Journal of Public Economics
  doi: 10.1016/j.jpubeco.2012.10.003
  contributor:
    fullname: Blume-Kohout
– volume: 7
  start-page: 1
  year: 1998
  ident: 10.1016/j.jhealeco.2013.06.001_bib0180
  article-title: Patent breadth, patent life, and the pace of technological progress
  publication-title: Journal of Economics and Management Strategy
  doi: 10.1111/j.1430-9134.1998.00001.x
  contributor:
    fullname: O’Donoghue
– volume: 9
  start-page: 81
  year: 2004
  ident: 10.1016/j.jhealeco.2013.06.001_bib0185
  article-title: Patents in a Model of Endogenous Growth
  publication-title: Journal of Economic Growth
  doi: 10.1023/B:JOEG.0000023017.42109.c2
  contributor:
    fullname: O’Donoghue
– volume: 111
  start-page: C164
  year: 2001
  ident: 10.1016/j.jhealeco.2013.06.001_bib0170
  article-title: On the policy implications of endogenous technological progress
  publication-title: Economic Journal
  doi: 10.1111/1468-0297.00626
  contributor:
    fullname: Li
– volume: 21
  start-page: 106
  year: 1990
  ident: 10.1016/j.jhealeco.2013.06.001_bib0105
  article-title: Optimal patent length and breadth
  publication-title: RAND Journal of Economics
  doi: 10.2307/2555497
  contributor:
    fullname: Gilbert
– year: 2011
  ident: 10.1016/j.jhealeco.2013.06.001_bib0120
  contributor:
    fullname: Grossmann
– volume: 23
  start-page: 52
  year: 1992
  ident: 10.1016/j.jhealeco.2013.06.001_bib0085
  article-title: Patent policy and costly imitation
  publication-title: RAND Journal of Economics
  doi: 10.2307/2555432
  contributor:
    fullname: Gallini
– year: 1991
  ident: 10.1016/j.jhealeco.2013.06.001_bib0225
  contributor:
    fullname: Sutton
– volume: 72
  start-page: 389
  year: 1982
  ident: 10.1016/j.jhealeco.2013.06.001_bib0080
  article-title: National and international returns to scale in the modern theory of international trade
  publication-title: American Economic Review
  contributor:
    fullname: Ethier
– volume: 102
  start-page: 1
  year: 2013
  ident: 10.1016/j.jhealeco.2013.06.001_bib0155
  article-title: Health insurance as a two-part pricing contract
  publication-title: Journal of Public Economics
  doi: 10.1016/j.jpubeco.2013.03.001
  contributor:
    fullname: Lakdawalla
– year: 1998
  ident: 10.1016/j.jhealeco.2013.06.001_bib0230
  contributor:
    fullname: Sutton
– volume: 76
  start-page: 351
  year: 2009
  ident: 10.1016/j.jhealeco.2013.06.001_bib0050
  article-title: Pharmaceutical patents: incentives for research and development or marketing?
  publication-title: Southern Economic Journal
  doi: 10.4284/sej.2009.76.2.351
  contributor:
    fullname: Brekke
– volume: 14
  start-page: 1
  year: 2005
  ident: 10.1016/j.jhealeco.2013.06.001_bib0245
  article-title: Examining the link between price regulation and pharmaceutical R&D investment
  publication-title: Health Economics
  doi: 10.1002/hec.897
  contributor:
    fullname: Vernon
– volume: 93
  start-page: 541
  year: 2009
  ident: 10.1016/j.jhealeco.2013.06.001_bib0150
  article-title: Innovation and the welfare effects of public drug insurance
  publication-title: Journal of Public Economics
  doi: 10.1016/j.jpubeco.2008.11.003
  contributor:
    fullname: Lakdawalla
– volume: 28
  start-page: 125
  year: 2009
  ident: 10.1016/j.jhealeco.2013.06.001_bib0220
  article-title: The effect of pharmaceutical regulation on revenues
  publication-title: Health Affairs
  doi: 10.1377/hlthaff.28.1.w125
  contributor:
    fullname: Sood
– volume: 116
  start-page: 1
  year: 2002
  ident: 10.1016/j.jhealeco.2013.06.001_bib0070
  article-title: The regulation of entry
  publication-title: Quarterly Journal of Economics
  doi: 10.1162/003355302753399436
  contributor:
    fullname: Djankov
– year: 1979
  ident: 10.1016/j.jhealeco.2013.06.001_bib0165
  contributor:
    fullname: Lancaster
SSID ssj0000539
Score 2.1900682
Snippet This paper examines the role of both cost-sharing schemes in health insurance systems and the regulation of entry into the pharmaceutical sector for...
SourceID proquest
crossref
pubmed
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 881
SubjectTerms Coinsurance
Control
Cost engineering
Cost Sharing
Deregulation
Drug and Narcotic Control - legislation & jurisprudence
Drug Costs
Drug Discovery
Drug Industry - legislation & jurisprudence
Economics
Entry deregulation
Expenditures
Health
Health administration
Health insurance
Labor
Models, Statistical
Patent breadth
Patents as Topic
Pharmaceutical industry
Pharmaceutical innovation
Pharmaceuticals
Price regulations
Productivity
Research & development expenditures
Studies
United States
Title Do cost-sharing and entry deregulation curb pharmaceutical innovation?
URI https://dx.doi.org/10.1016/j.jhealeco.2013.06.001
https://www.ncbi.nlm.nih.gov/pubmed/23896384
https://www.proquest.com/docview/1440135866
https://search.proquest.com/docview/1443406520
https://search.proquest.com/docview/1685785641
Volume 32
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELZoe0FCqDy7UJCRuEUuSRzH9qmq2C2FA5cW1FsUOw7tFjZVd_f_MxM7j1LKQ4hLtPLmYc-MZ8bjGX-EvFa5rKURJautdgxmomBaV4457UpdJRWPa4xDHh3Lj6dqOstmA9ro0PZfOQ1twGusnP0LbvcvhQb4DTyHK3Adrn_E92kT2Wa5Ysuzsi9AbNFDIoTl_BLQuiK7vjLR5dm1gPZ5j5D6Q7rfyGv1dZORC_XMvUf-Dq3tt4C4_Ln5ehGyfkNAAcEd9DigcLPSxQceQaHmqQ7HVntlqaRmeD7ZWJsO0cphv9rbVQ_N0llZD218Q4H7WMJ8b976yRbLMxO-53eMBpPVJxIeY7-wW7grFyupNshWCioHNN7WwfvZ6YfBKosWVa4fx6ha_Odfu81RuW0h0jokJ9vkfuAJPfAi8IDccYuH5J4Pw1JfXfaIHE4bOhYHCuJAW3GgY3GgKA70ujjQQRz2H5NPh7OTt0csQGcwK7JkxbKa89RaqWB1KlwtXJKJLCth7tk0rWrthJQWF9sO_WtjrMANuQrcNROXQEb-hGwumoXbIVRyVUsEfgSdkyluTG6FMTKuZVUZnuQT8qajU3HpT0gputTBedFRtkDKFj6HckJ0R84i-HnefytACn777G5H_yLMumWBCQoJFzDYCXnV_w16Eje_yoVr1u09HJxXkca_uCdXePZTnsFnnnre9kMC1xZtVfbsHzr_nNwdJtwu2Vxdrd0LsrGs1i-DuH4Hv-OiUg
link.rule.ids 315,782,786,27933,27934
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Do+cost-sharing+and+entry+deregulation+curb+pharmaceutical+innovation%3F&rft.jtitle=Journal+of+health+economics&rft.au=Grossmann%2C+Volker&rft.date=2013-09-01&rft.pub=Elsevier+B.V&rft.issn=0167-6296&rft.eissn=1879-1646&rft.volume=32&rft.issue=5&rft.spage=881&rft.epage=894&rft_id=info:doi/10.1016%2Fj.jhealeco.2013.06.001&rft.externalDocID=S0167629613000878
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0167-6296&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0167-6296&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0167-6296&client=summon